4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001532218-26-000004
CHAIRMAN & CEO sold 7,278 shares at $50.01 ($363,973)
- CHAIRMAN & CEO gave up 4,831 shares (to pay taxes)
- CHAIRMAN & CEO acquired 17,269 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Sanj K · CHAIRMAN & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,278 | $10.36 | $75,400 | 7,278 | D |
| 2026-04-06 | Sale : show line 2 in the form 10b5-1 | −7,278 | $50.01 | $363,973 | 0 | D |
| 2026-04-07 | Exercise or conversion : show line 3 in the form 10b5-1 | +9,991 | 81,005 | I | ||
| 2026-04-07 | Shares withheld for taxes : show line 4 in the form 10b5-1 | −4,831 | $48.94 | $236,429 | 76,174 | I |
| Open-market sales · 7,278 sh · avg $50.01 · $363,973 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-06 | Exercise or conversion : show line 5 in the form 10b5-1 Share Option | −7,278 | 431,904 | D |
| 2026-04-07 | Exercise or conversion : show line 6 in the form 10b5-1 Restricted Share Unit | −9,991 | 0 | D |
Loading xslF345X06/form4-04082026_080403.xml…